Literature DB >> 15872215

Osteoporosis, teriparatide, and dosing of calcium and vitamin D.

Angelo A Licata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872215     DOI: 10.1056/NEJM200505053521822

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report.

Authors:  Krupa B Doshi; Amir H Hamrahian; Angelo A Licata
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

2.  Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Authors:  R A Wermers; C P Recknor; F Cosman; L Xie; E V Glass; J H Krege
Journal:  Osteoporos Int       Date:  2008-02-19       Impact factor: 4.507

Review 3.  Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults.

Authors:  Roberto Cesareo; Roberto Attanasio; Marco Caputo; Roberto Castello; Iacopo Chiodini; Alberto Falchetti; Rinaldo Guglielmi; Enrico Papini; Assunta Santonati; Alfredo Scillitani; Vincenzo Toscano; Vincenzo Triggiani; Fabio Vescini; Michele Zini
Journal:  Nutrients       Date:  2018-04-27       Impact factor: 5.717

4.  Hypercalcemic encephalopathy due to milk alkali syndrome and injection teriparatide.

Authors:  Sandeep Kharb; Abhay Gundgurthi; Aditi Pandit; Karninder S Brar; M K Garg
Journal:  Indian J Endocrinol Metab       Date:  2012-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.